The Exosomal miR-130b-5p Derived From Crohn's Disease-Associated Mesenteric Adipose Tissue Promotes Ileocolonic

Enhao Wu1, Wenwei Qian2, Zhenxing Zhu3

  • 1Department of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.

Insights

Hypertrophic mesenteric adipose tissue (HtMAT) in Crohn's disease releases exosomes containing miR-130b-5p. These exosomes activate fibroblasts, promoting anastomotic fibrosis via the Smad signaling pathway, contributing to disease recurrence.

Area of Science:

  • Gastroenterology
  • Cell Biology
  • Molecular Medicine

Background:

  • Mesenteric tissue fibrosis correlates with Crohn's disease severity.
  • The role of hypertrophic mesenteric adipose tissue (HtMAT) in Crohn's disease (CD) pathogenesis, particularly in anastomotic recurrence, is unclear.

Purpose of the Study:

  • To investigate the role of exosomes from HtMAT in promoting ileocolonic anastomotic fibrosis and fibroblast activation in CD.
  • To elucidate the underlying molecular mechanisms involving microRNAs.

Main Methods:

  • Exosomes were isolated from HtMAT and normal mesenteric adipose tissue (nMAT) of CD patients.
  • In vitro and in vivo experiments using a surgical model in IL10 knockout mice.
  • MicroRNA microarray, Western blot, luciferase assay, and immunofluorescence were employed.

Main Results:

  • Exosomes from HtMAT (HtMAT-Exos) dose-dependently activated fibroblasts and promoted intestinal fibrosis.
  • Exosomal miR-130b-5p was enriched in HtMAT-Exos and mediated fibroblast activation.
  • miR-130b-5p targeted TGFBR3, leading to Smad2/3 phosphorylation and promoting fibrosis.

Conclusions:

  • Exosomal miR-130b-5p derived from HtMAT promotes ileocolonic anastomotic fibrosis by activating fibroblasts through the Smad signaling pathway.
  • HtMAT significantly contributes to anastomotic fibrosis in CD, highlighting a potential therapeutic target.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K